Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1375466-18-4 Chemical Structure| 1375466-18-4

Structure of ACY-775
CAS No.: 1375466-18-4

Chemical Structure| 1375466-18-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ACY-775 is a potent and selective inhibitor of the of histone deacetylase 6 (HDAC6) with an IC50 of 7.5 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ACY-775

CAS No. :1375466-18-4
Formula : C17H19FN4O2
M.W : 330.36
SMILES Code : O=C(C1=CN=C(NC2(C3=CC=CC(F)=C3)CCCCC2)N=C1)NO
MDL No. :MFCD30533691
InChI Key :IYBURCQQEUNLDL-UHFFFAOYSA-N
Pubchem ID :57382288

Safety of ACY-775

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H315-H319-H228
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of ACY-775

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RN46A-B14 cells 2.5 μM 4 h To evaluate the inhibitory effect of ACY-775 on HDAC6 and its impact on α-tubulin acetylation. Results showed that ACY-775 significantly increased the acetylation of α-tubulin but had no significant effect on histone H3K9 acetylation. Neuropsychopharmacology. 2014 Jan;39(2):389-400.
Dorsal root ganglion (DRG) neurons 2.5 μM Overnight To evaluate the ability of ACY-738 and ACY-775 to restore mitochondrial axonal transport defects. Results showed that both inhibitors significantly increased mitochondrial motility and total number, and significantly enhanced the number of retrogradely transported mitochondria. Neurotherapeutics. 2017 Apr;14(2):417-428.
Mouse neuroblastoma (N2a) cells 1 μM Overnight To assess the effect of ACY-738 and ACY-775 on the acetylation status of α-tubulin and histone 3. Results showed that both inhibitors significantly enhanced α-tubulin acetylation at 1 μM concentration, while histone acetylation remained unaffected. Neurotherapeutics. 2017 Apr;14(2):417-428.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice NIH Swiss mice Intraperitoneal injection 50 mg/kg Single administration To evaluate the antidepressant-like effects of ACY-775 in vivo. Results showed that ACY-775 significantly reduced immobility time in the tail suspension test, demonstrating antidepressant-like effects. Additionally, ACY-775 increased α-tubulin acetylation levels in the brain. Neuropsychopharmacology. 2014 Jan;39(2):389-400.
Mice HSPB1 S135F-induced CMT2 mouse model Intraperitoneal injection 3 mg/kg Once daily for 21 days To evaluate the effect of ACY-775 on reversing motor and sensory deficits in the CMT2 mouse model. Results showed that ACY-775 significantly improved motor and sensory nerve action potential amplitudes and increased reinnervation of neuromuscular junctions. Neurotherapeutics. 2017 Apr;14(2):417-428.
Macaque Macaque model Intravenous injection 0.1 and 2 mg/kg Single dose, lasting 120 minutes Compare HDAC6 target occupancy between EKZ-317 and ACY-775, showing that EKZ-317 achieved high occupancy (≥90%) at both 0.1 and 2 mg/kg doses, while ACY-775 only achieved similar occupancy at 2 mg/kg dose ACS Chem Neurosci. 2020 Apr 1;11(7):1093-1101

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.03mL

0.61mL

0.30mL

15.14mL

3.03mL

1.51mL

30.27mL

6.05mL

3.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories